Market Cap 563.41M
Revenue (ttm) 3.55M
Net Income (ttm) -187.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5,277.47%
Debt to Equity Ratio 0.00
Volume 1,218,300
Avg Vol 1,114,180
Day's Range N/A - N/A
Shares Out 40.56M
Stochastic %K 88%
Beta 1.39
Analysts Strong Sell
Price Target $29.00

Latest News on KROS

Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump

Apr 10, 2025, 12:12 PM EDT - 13 days ago

Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump


Keros Therapeutics adopts 'poison pill' plan

Apr 10, 2025, 6:10 AM EDT - 13 days ago

Keros Therapeutics adopts 'poison pill' plan


Keros Therapeutics Announces Review of Strategic Alternatives

Apr 10, 2025, 6:00 AM EDT - 13 days ago

Keros Therapeutics Announces Review of Strategic Alternatives


Keros halts hypertension treatment trial on safety issues

Jan 15, 2025, 6:41 AM EST - 3 months ago

Keros halts hypertension treatment trial on safety issues